In accordance with these observations, mouse models deficient in Nrf2 or the receptor CX3CR1 exhibit increased microglial and astroglial activation, suggesting a pivotal role for the CX3CL1/Nrf2 axis in modulating the neuroinflammatory response in AD [47]. Here, CX3CL1 is linked to Alzheimer disease.